Radiotherapy omission in low-risk hormone receptor–positive breast cancer: insights from a Korean single-center cohort

Haeyoung Kim · 2025

Read Radiotherapy omission in low-risk hormone receptor–positive breast cancer: insights from a Korean single-center cohort by Haeyoung Kim (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12770875.txt.

Description

Haeyoung Kim, writing alone, comments on skipping radiotherapy in low-risk breast cancer in this 2025 editorial. Removing the breast tumor and following with radiation has long been the standard for early disease. As hormone therapy spread, doctors have hunted for a low-risk group that could safely skip radiation.

Kim reviews the major trials and pooled analyses, which agree that even the lowest-risk patients face more local recurrence without radiation. The editorial discusses a new Korean single-center report on a narrow group: postmenopausal women with small, low-grade, hormone-positive tumors and a low growth marker. Careful thought is still required before omitting radiation, Kim concludes.

Catalog record

CREATORHaeyoung Kim
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE6 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12770875

Browse the full library · About the Tower of Babel